ID   DYR1B_HUMAN             Reviewed;         629 AA.
AC   Q9Y463; O75258; O75788; O75789;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   02-NOV-2010, entry version 107.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 1B;
DE            EC=2.7.12.1;
DE   AltName: Full=Minibrain-related kinase;
DE   AltName: Full=Mirk protein kinase;
GN   Name=DYRK1B; Synonyms=MIRK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Testis;
RX   MEDLINE=99119336; PubMed=9918863; DOI=10.1006/bbrc.1998.9967;
RA   Leder S., Weber Y., Altafaj X., Estivill X., Joost H.-G., Becker W.;
RT   "Cloning and characterization of DYRK1B, a novel member of the DYRK
RT   family of protein kinases.";
RL   Biochem. Biophys. Res. Commun. 254:474-479(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND MUTAGENESIS OF LYS-140; TYR-271 AND TYR-273.
RC   TISSUE=Colon carcinoma;
RX   MEDLINE=20365433; PubMed=10910078;
RA   Lee K., Deng X., Friedman E.;
RT   "Mirk protein kinase is a mitogen-activated protein kinase substrate
RT   that mediates survival of colon cancer cells.";
RL   Cancer Res. 60:3631-3637(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH DCOHM; MAP2K3 AND TCF1.
RC   TISSUE=Muscle;
RX   MEDLINE=22095560; PubMed=11980910; DOI=10.1074/jbc.M203257200;
RA   Lim S., Jin K., Friedman E.;
RT   "Mirk protein kinase is activated by MKK3 and functions as a
RT   transcriptional activator of HNF1alpha.";
RL   J. Biol. Chem. 277:25040-25046(2002).
RN   [6]
RP   FUNCTION, DIMERIZATION, INTERACTION WITH RANBP9, AND IDENTIFICATION IN
RP   A COMPLEX WITH RAN; RANBP9 AND COPS5.
RX   PubMed=14500717; DOI=10.1074/jbc.M307556200;
RA   Zou Y., Lim S., Lee K., Deng X., Friedman E.;
RT   "Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial
RT   cell migration and is negatively regulated by the Met adaptor Ran-
RT   binding protein M.";
RL   J. Biol. Chem. 278:49573-49581(2003).
RN   [7]
RP   INTERACTION WITH DCAF7.
RX   PubMed=14593110; DOI=10.1074/jbc.M301769200;
RA   Skurat A.V., Dietrich A.D.;
RT   "Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family
RT   protein kinases.";
RL   J. Biol. Chem. 279:2490-2498(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-271 AND TYR-273, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-273, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-57, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-28; HIS-102; GLY-234 AND ARG-275.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual-specificity kinase which possesses both serine/
CC       threonine and tyrosine kinase activities. Enhances the
CC       transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits
CC       epithelial cell migration. Mediates colon carcinoma cell survival
CC       in mitogen-poor environments.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by RANBP9.
CC   -!- SUBUNIT: Dimer. Interacts with DCOHM, MAP2K3/MKK3, RANBP9 and
CC       TCF1/HNF1A. Part of a complex consisting of RANBP9, RAN, DYRK1B
CC       and COPS5. Interatcs with DCAF7.
CC   -!- INTERACTION:
CC       P20823:HNF1A; NbExp=3; IntAct=EBI-634187, EBI-636034;
CC       P46734:MAP2K3; NbExp=2; IntAct=EBI-634187, EBI-602462;
CC       Q9H0N5:PCBD2; NbExp=1; IntAct=EBI-634187, EBI-634289;
CC       Q96S59:RANBP9; NbExp=3; IntAct=EBI-634187, EBI-636085;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9Y463-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y463-2; Sequence=VSP_004925;
CC       Name=3;
CC         IsoId=Q9Y463-3; Sequence=VSP_004926;
CC   -!- TISSUE SPECIFICITY: Highest expression in skeletal muscle, testis,
CC       heart and brain with little expression in colon or lung. Expressed
CC       in a variety of tumor cell lines.
CC   -!- PTM: Autophosphorylated on tyrosine residues. Phosphorylated by
CC       MAP kinase. Tyrosine phosphorylation may be required for
CC       dimerization.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MNB/DYRK subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC28914.1; Type=Erroneous gene model prediction;
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DYRK1BID43235ch19q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y17999; CAA76991.1; -; mRNA.
DR   EMBL; Y17999; CAA76990.1; -; mRNA.
DR   EMBL; Y17999; CAA76989.1; -; mRNA.
DR   EMBL; AF205861; AAF15893.1; -; mRNA.
DR   EMBL; AC005393; AAC28914.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC018751; AAH18751.1; -; mRNA.
DR   EMBL; BC025291; AAH25291.1; -; mRNA.
DR   IPI; IPI00000352; -.
DR   IPI; IPI00215873; -.
DR   IPI; IPI00332215; -.
DR   PIR; JG0195; JG0195.
DR   RefSeq; NP_004705.1; -.
DR   RefSeq; NP_006474.1; -.
DR   RefSeq; NP_006475.1; -.
DR   UniGene; Hs.130988; -.
DR   ProteinModelPortal; Q9Y463; -.
DR   SMR; Q9Y463; 92-437.
DR   IntAct; Q9Y463; 12.
DR   MINT; MINT-2790122; -.
DR   STRING; Q9Y463; -.
DR   PhosphoSite; Q9Y463; -.
DR   PRIDE; Q9Y463; -.
DR   Ensembl; ENST00000323039; ENSP00000312789; ENSG00000105204.
DR   GeneID; 9149; -.
DR   KEGG; hsa:9149; -.
DR   UCSC; uc002omi.1; human.
DR   UCSC; uc002omj.1; human.
DR   UCSC; uc002omk.1; human.
DR   CTD; 9149; -.
DR   GeneCards; GC19M040316; -.
DR   H-InvDB; HIX0202834; -.
DR   HGNC; HGNC:3092; DYRK1B.
DR   MIM; 604556; gene.
DR   PharmGKB; PA27549; -.
DR   eggNOG; prNOG14617; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG051425; -.
DR   InParanoid; Q9Y463; -.
DR   OMA; LVGGPPD; -.
DR   OrthoDB; EOG9GMXG8; -.
DR   PhylomeDB; Q9Y463; -.
DR   BRENDA; 2.7.12.1; 247.
DR   NextBio; 34319; -.
DR   ArrayExpress; Q9Y463; -.
DR   Bgee; Q9Y463; -.
DR   CleanEx; HS_DYRK1B; -.
DR   Genevestigator; Q9Y463; -.
DR   GermOnline; ENSG00000105204; Homo sapiens.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-d...; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    629       Dual specificity tyrosine-
FT                                phosphorylation-regulated kinase 1B.
FT                                /FTId=PRO_0000085934.
FT   DOMAIN      111    431       Protein kinase.
FT   NP_BIND     117    125       ATP (By similarity).
FT   REGION      480    520       Interaction with RANBP9.
FT   MOTIF        69     86       Bipartite nuclear localization signal
FT                                (Potential).
FT   COMPBIAS    558    561       Poly-Pro.
FT   ACT_SITE    239    239       Proton acceptor (By similarity).
FT   BINDING     140    140       ATP (By similarity).
FT   MOD_RES      57     57       N6-acetyllysine.
FT   MOD_RES     271    271       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     273    273       Phosphotyrosine; by autocatalysis.
FT   VAR_SEQ     366    405       Missing (in isoform 2).
FT                                /FTId=VSP_004925.
FT   VAR_SEQ     378    405       Missing (in isoform 3).
FT                                /FTId=VSP_004926.
FT   VARIANT      28     28       L -> P (in dbSNP:rs34587974).
FT                                /FTId=VAR_040454.
FT   VARIANT     102    102       R -> H (in dbSNP:rs55687541).
FT                                /FTId=VAR_040455.
FT   VARIANT     234    234       S -> G (in dbSNP:rs35858874).
FT                                /FTId=VAR_040456.
FT   VARIANT     275    275       Q -> R (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040457.
FT   MUTAGEN     140    140       K->R: Abolishes kinase activity.
FT   MUTAGEN     271    271       Y->F: Abolishes kinase activity; when
FT                                associated with F-273.
FT   MUTAGEN     273    273       Y->F: Abolishes kinase activity; when
FT                                associated with F-271.
SQ   SEQUENCE   629 AA;  69198 MW;  D7C354AC55943A8B CRC64;
     MAVPPGHGPF SGFPGPQEHT QVLPDVRLLP RRLPLAFRDA TSAPLRKLSV DLIKTYKHIN
     EVYYAKKKRR AQQAPPQDSS NKKEKKVLNH GYDDDNHDYI VRSGERWLER YEIDSLIGKG
     SFGQVVKAYD HQTQELVAIK IIKNKKAFLN QAQIELRLLE LMNQHDTEMK YYIVHLKRHF
     MFRNHLCLVF ELLSYNLYDL LRNTHFRGVS LNLTRKLAQQ LCTALLFLAT PELSIIHCDL
     KPENILLCNP KRSAIKIVDF GSSCQLGQRI YQYIQSRFYR SPEVLLGTPY DLAIDMWSLG
     CILVEMHTGE PLFSGSNEVD QMNRIVEVLG IPPAAMLDQA PKARKYFERL PGGGWTLRRT
     KELRKDYQGP GTRRLQEVLG VQTGGPGGRR AGEPGHSPAD YLRFQDLVLR MLEYEPAARI
     SPLGALQHGF FRRTADEATN TGPAGSSAST SPAPLDTCPS SSTASSISSS GGSSGSSSDN
     RTYRYSNRYC GGPGPPITDC EMNSPQVPPS QPLRPWAGGD VPHKTHQAPA SASSLPGTGA
     QLPPQPRYLG RPPSPTSPPP PELMDVSLVG GPADCSPPHP APAPQHPAAS ALRTRMTGGR
     PPLPPPDDPA TLGPHLGLRG VPQSTAASS
//
